ONCO Onconetix, Inc.

Nasdaq onconetix.gcs-web.com


$ 2.71 $ -0.03 (-1.09 %)    

Monday, 10-Nov-2025 16:09:27 EST
QQQ $ 623.82 $ 4.38 (0.71 %)
DIA $ 473.95 $ 1.94 (0.41 %)
SPY $ 681.69 $ 4.15 (0.61 %)
TLT $ 89.46 $ 0.06 (0.07 %)
GLD $ 380.15 $ 2.40 (0.64 %)
$ 2.71
$ 2.79
$ 2.66 x 1
$ 3.14 x 10
$ 2.68 - $ 2.88
$ 2.45 - $ 215.05
26,130
na
1.54M
$ 2.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 06-12-2025 03-31-2025 10-Q
3 06-02-2025 12-31-2024 10-K
4 12-10-2024 09-30-2024 10-Q
5 08-29-2024 06-30-2024 10-Q
6 05-20-2024 03-31-2024 10-Q
7 04-11-2024 12-31-2023 10-K
8 11-17-2023 09-30-2023 10-Q
9 10-20-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

-SEC Filing

Core News & Articles

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

Core News & Articles

Onconetix, Inc. (NASDAQ:ONCO) ("Onconetix" or the "Company") a commercial stage biotechnology company focused o...

Core News & Articles

Onconetix (NASDAQ:ONCO) reported quarterly losses of $(4.76) per share. This is a 99.78 percent increase over losses of $(2.19 ...

Core News & Articles

Pursuant to the Merger Agreement, Onconetix will acquire all of the issued and outstanding equity interests of Ocuvex and, in c...

Core News & Articles

Onconetix, Inc. (NASDAQ:ONCO) ("Onconetix" or the "Company"), a commercial-stage biotechnology company focused ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION